Etiometry
Transforming critical care data into clinical insights.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor | €0.0 | round | |
* | N/A | $10.0m | Debt |
| Total Funding | 000k | ||
| USD | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 22 % | 3 % | 15 % | 23 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Etiometry Inc. specializes in analytics-based clinical decision support software designed for intensive care units (ICUs). The company leverages advanced data aggregation, integration, and analytics platforms to provide clinicians with actionable insights that improve patient outcomes, enhance the efficiency of care delivery, and reduce healthcare costs. Etiometry's software aggregates data from multiple sources, synthesizes it to reveal potential risks, and presents it in a physiological context, enabling clinicians to make more informed decisions. The primary clients are hospitals and healthcare providers operating in the critical care market. The business model revolves around a subscription-based service, where clients pay for access to the software and its continuous updates. Revenue is generated through these subscriptions and additional services such as training and support.
Keywords: clinical decision support, intensive care, data analytics, patient health, care efficiency, data aggregation, risk analytics, healthcare software, critical care, subscription-based.